The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 24, 2010
Filed:
Feb. 21, 2006
Partha Neogi, Fremont, CA (US);
Bishwajit Nag, Union City, CA (US);
Debendranath Dey, Fremont, CA (US);
Abhijeet Nag, Fremont, CA (US);
Birendra Kumar Bhattacharya, Union City, CA (US);
Vinod Kumar Singh, Sholinganallur, IN;
Surendradoss Jayakumar, Sholinganallur, IN;
Partha Neogi, Fremont, CA (US);
Bishwajit Nag, Union City, CA (US);
Debendranath Dey, Fremont, CA (US);
Abhijeet Nag, Fremont, CA (US);
Birendra Kumar Bhattacharya, Union City, CA (US);
Vinod Kumar Singh, Sholinganallur, IN;
Surendradoss Jayakumar, Sholinganallur, IN;
Bexel Pharmaceuticals, Inc., Union City, CA (US);
Abstract
The present invention relates to novel heterocyclic diphenyl ether and diphenyl amine compounds, derivatives, analogs, tautomeric forms, stereoisomers, polymorphs, hydrates, solvates, pharmaceutically acceptable salts and pharmaceutically acceptable solvates thereof and pharmaceutically acceptable compositions containing these singly or in combination. The compounds of the present invention are effective in lowering blood glucose, serum insulin, free fatty acids, cholesterol and triglyceride levels and are useful in the treatment and/or prophylaxis of diabetes. The compounds of the present invention are effective in treatment of obesity, inflammation, autoimmune diseases such as multiple sclerosis and rheumatoid arthritis and immunological diseases, including the treatment of cancer. Furthermore, the compounds are useful for the treatment of disorders associated with insulin resistance.